(Q37803221)

23 August 2017

Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease (English)

1 reference

23 August 2017

0 references

0 references

Karl Herholz

1

1 reference

23 August 2017

1 November 2010

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

23 August 2017

1 reference

23 August 2017

10

1 reference

23 August 2017

11

1 reference

23 August 2017

1667-1673

1 reference

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

23 August 2017

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Mild cognitive impairment as a clinical entity and treatment target

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

21 January 2018

PET studies in dementia

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Impairment of neocortical metabolism predicts progression in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Diagnostic features of Alzheimer's disease extracted from PET sinograms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Principal component analysis of FDG PET in amnestic MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

On the multivariate nature of brain metabolic impairment in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Statistical parametric maps in functional imaging: A general linear approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Hippocampal formation glucose metabolism and volume losses in MCI and AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Positron emission tomography partial volume correction: estimation and algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Cortical flattening applied to high-resolution 18F-FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

In vivo validation of reconstruction-based resolution recovery for human brain studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Where the brain grows old: decline in anterior cingulate and medial prefrontal function with normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Differences in cerebral metabolic impairment between early and late onset types of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Differential hypometabolism patterns according to mild cognitive impairment subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Association of elevated phospho-tau levels with Alzheimer-typical 18F-fluoro-2-deoxy-D-glucose positron emission tomography findings in patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Comparing predictors of conversion and decline in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

(18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: a SPECT blood flow study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Abnormalities of regional brain metabolism in Alzheimer's disease and their relation to functional impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: relationship to degree of deterioration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Integrating ADNI results into Alzheimer's disease drug development programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Subregional neuroanatomical change as a biomarker for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

Comparison of 18F-FDG and PiB PET in cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.136

21 January 2018

Identifiers

DOI

10.1586/ERN.10.136

1 reference

23 August 2017

1 reference

PubMed ID

20977325